Melbourne study links higher tumour radiation dose to longer progression-free survival

July 10, 2026 Latest News Other Health

This is a preview of subscriber content

Subscribe now to continue reading.

Researchers in Melbourne have reported an association between the radiation dose tumours receive during radiopharmaceutical therapy and progression-free survival in patients with metastatic castration resistant prostate cancer. …

Subscribe now to continue reading.

Latest Video

'But I've said it's really important that these two drugs stay on the PBS'
July 7, 2026 - Latest News
In a perfect world, the minister would not be in this position, and he might question the timeline
July 8, 2026 - Latest News
Aegros completes Australia’s second large scale plasma fractionation plant
July 8, 2026 - Latest News
Illumina taps medtech leader to head Australia and New Zealand operations
July 8, 2026 - Latest News
It might make sense to follow the process, mostly, but no need to keep patients waiting
July 9, 2026 - Latest News

Melbourne study links higher tumour radiation dose to longer progression-free survival

This is a preview of subscriber content

Latest Video

Most Read

'But I've said it's really important that these two drugs stay on the PBS'

In a perfect world, the minister would not be in this position, and he might question the timeline

Aegros completes Australia’s second large scale plasma fractionation plant

Illumina taps medtech leader to head Australia and New Zealand operations

It might make sense to follow the process, mostly, but no need to keep patients waiting

New Stories

Disruption is the overdue remedy and how this debate can revitalise the PBS

Melbourne study links higher tumour radiation dose to longer progression-free survival

Older Australians are underestimating their personal risk from RSV

Territory partnership backs digital health push for diabetes, kidney and heart care

It might make sense to follow the process, mostly, but no need to keep patients waiting

Illumina taps medtech leader to head Australia and New Zealand operations

PYC Therapeutics names Thomas Ulmer as new chief financial officer

Sign In

Melbourne study links higher tumour radiation dose to longer progression-free survival

This is a preview of subscriber content

Latest Video

Most Read

'But I've said it's really important that these two drugs stay on the PBS'

In a perfect world, the minister would not be in this position, and he might question the timeline

Aegros completes Australia’s second large scale plasma fractionation plant

Illumina taps medtech leader to head Australia and New Zealand operations

It might make sense to follow the process, mostly, but no need to keep patients waiting

Follow Us

New Stories

Disruption is the overdue remedy and how this debate can revitalise the PBS

Melbourne study links higher tumour radiation dose to longer progression-free survival

Older Australians are underestimating their personal risk from RSV

Territory partnership backs digital health push for diabetes, kidney and heart care

It might make sense to follow the process, mostly, but no need to keep patients waiting

Illumina taps medtech leader to head Australia and New Zealand operations

PYC Therapeutics names Thomas Ulmer as new chief financial officer